XML 78 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Net Income per Common Share
 3 Months Ended
Mar. 24, 2013
Net income (loss) per common share [Abstract]  
Net Income per Common Share
14. Net Income per Common Share

The Company calculates earnings per share using the two-class method.  The two-class method requires allocating the Company's net income to both common shares and participating securities.  The Company's participating securities include the unvested, outstanding RSUs to the extent the RSUs provide for the right to receive dividend equivalents.
The following table provides a reconciliation of the numerator and denominator of the basic and diluted per-share computations for the three and nine months ended March 24, 2013 and March 25, 2012 (in thousands, except per share amounts):
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
March 24, 2013
 
 
March 25, 2012
 
 
March 24, 2013
 
 
March 25, 2012
 
Net income (loss)  
 
$
(21,245
)
 
$
(2,490
)
 
$
(82,742
)
 
$
13,136
 
Less: Income allocated to participating securities
 
 
—
 
 
 
—
 
 
 
—
 
 
 
148
 
Income (loss) available to common stockholders
 
$
(21,245
)
 
$
(2,490
)
 
$
(82,742
)
 
$
12,988
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average common shares outstanding
 
 
69,273
 
 
 
69,104
 
 
 
69,234
 
 
 
69,306
 
Net income (loss) per common share-basic
 
$
(0.31
)
 
$
(0.04
)
 
$
(1.20
)
 
$
0.19
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diluted
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic weighted average common shares outstanding
 
 
69,273
 
 
 
69,104
 
 
 
69,234
 
 
 
69,306
 
Effect of dilutive securities – stock options and RSUs
 
 
—
 
 
 
—
 
 
 
—
 
 
 
505
 
Weighted-average common shares and potentially dilutive securities outstanding-dilutive
 
 
69,273
 
 
 
69,104
 
 
 
69,234
 
 
 
69,811
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) per common share-dilutive
 
$
(0.31
)
 
$
(0.04
)
 
$
(1.20
)
 
$
0.19
 


For the three and nine months ended March 24, 2013, 1.2 million shares and 2.2 million shares of common stock equivalents, respectively, were antidilutive and were not included in the computation of diluted earnings per share for these periods.  Additionally, for the three and nine months ended March 25, 2012, 0.9 million shares and 0.3 million shares of common stock equivalents, respectively, were antidilutive and were not included in the computation of diluted earnings per share for these periods.  In addition, for the three and nine months ended March 24, 2013, 0.8 million shares and 0.8 million shares, respectively, of contingently issuable restricted stock units for which all necessary conditions had not been met were not included in the computation of diluted earnings per share.